OncoSenX
0 followers
‌
OncoSenX is a late stage pre-clinical cancer company headquartered in Seattle, Washington. OncoSenX targets solid tumors based on transcriptional activity using a unique lipid nanoparticle and plasmid DNA.
Industries
Headquarters
Employees
Links
Org chart
Matthew Scholz
Collapse
John D. Lewis
Founder, CSO
Eric Garcia
COO
Stephen Hilbert
Chief Business Officer
David Fuller
Investor
Gary Hudson
Executive Chairman
Hank Garcia
Senior Scientist
